Replies to post #194668 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

You raise a very good point Virgilio. I noticed the TOCA 511 (TOCAGEN) trial completed enrollment last month in a 380 patient recurrent high grade glioma trial. GBM (phase II) and AA (phase III).

Guess who was the principle investigator?

Principal Investigator: Timothy Cloughesy, MD University of California, Los Angeles


Now that TOCA 511 is enrolled, you'd think he might be able to get the DCVax-L recurrent GBM trial started.

You'd think. You also might think he has a pool of people that did not quite make it into the TOCA 511 trial.

You'd think.

I wonder if a lot of people that thought they might apply for the DCVax-L recurrent trial ended up in the Tocagen trial?